News Axsome Therapeutics Reports P-III (FOCUS) Trial Data of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD)ByRidhi RastogiMarch 26, 20250Comments
News Huntleigh Healthcare Reports the US FDA’s 510(k) Clearance of Dawes-Redman CTG Analysis to Improve Non-Stress Test Interpretation in FetusesByRidhi RastogiMarch 26, 20250Comments
News Accent Therapeutics to Highlight Preclinical Data of ATX-559 and ATX-295 at AACR 2025ByRidhi RastogiMarch 26, 20250Comments
News GSK Reports the US FDA’s Approval of Blujepa (Gepotidacin) to Treat Uncomplicated Urinary Tract Infections (uUTIs)ByDipanshu DixitMarch 26, 20250Comments
INSIGHTS+ Disease of the Month – Lennox-Gastaut syndrome (LGS)ByDipanshu DixitMarch 26, 20250Comments
News Merck Partners with Jiangsu Hengrui Pharmaceuticals for HRS-5346, Expanding its Cardio-Metabolic PortfolioByRidhi RastogiMarch 25, 20250Comments
News Alumis and Kaken Pharmaceutical Enter Collaboration & Licencing Deal for ESK-001’s Development & Commercialization in JapanByRidhi RastogiMarch 25, 20250Comments
News AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025ByRidhi RastogiMarch 25, 20250Comments
News Sanofi Reports the US FDA’s Acceptance & Priority Review of Tolebrutinib for Non-Relapsing Secondary Progressive Multiple SclerosisByRidhi RastogiMarch 25, 20250Comments
